Vitamin A Deficiency
Overview
Plain-Language Overview
Vitamin A deficiency is a condition where the body lacks enough vitamin A, an essential nutrient important for maintaining healthy vision, skin, and immune function. People with this deficiency may experience problems seeing in low light or at night, a symptom known as night blindness. The skin can become dry and rough, and the eyes may develop dryness or more serious damage. This condition is more common in areas where diets lack sufficient vitamin A or in people with certain medical problems that affect nutrient absorption. Without enough vitamin A, the body's ability to fight infections can also be weakened.
Clinical Definition
Vitamin A deficiency is a clinical condition characterized by insufficient levels of retinol and its derivatives in the body, leading to impaired function of multiple organ systems. It primarily affects the visual system, causing symptoms such as night blindness and xerophthalmia, which includes conjunctival and corneal dryness and keratomalacia. The deficiency results from inadequate dietary intake, malabsorption syndromes, or increased metabolic demand. Biochemically, it is marked by low serum retinol concentrations, typically below 0.70 µmol/L. The deficiency disrupts the normal function of rhodopsin in retinal photoreceptors, impairing dark adaptation. Additionally, vitamin A is crucial for maintaining epithelial integrity and immune competence, so deficiency can lead to increased susceptibility to infections and skin changes like follicular hyperkeratosis. Chronic deficiency may cause irreversible blindness and increased childhood mortality. Diagnosis involves clinical assessment and laboratory measurement of serum retinol, with consideration of underlying causes such as malnutrition or liver disease.
Inciting Event
- Dietary deficiency due to inadequate intake of vitamin A-rich foods.
- Onset of a malabsorption disorder impairing vitamin A absorption.
- Increased vitamin A demand during infection or pregnancy.
Latency Period
- Symptoms typically develop after months to years of inadequate vitamin A intake.
Diagnostic Delay
- Early symptoms like night blindness are often subtle and overlooked.
- Lack of awareness about vitamin A deficiency in non-endemic areas.
- Misattribution of ocular symptoms to other eye diseases.
Clinical Presentation
Signs & Symptoms
- Night blindness (nyctalopia) as an early symptom due to impaired rod function.
- Dryness of the conjunctiva and cornea (xerophthalmia).
- Bitot spots on the conjunctiva.
- Increased susceptibility to infections due to impaired mucosal immunity.
- Dry, scaly skin and follicular hyperkeratosis.
History of Present Illness
- Progressive difficulty seeing in dim light or at night (night blindness).
- Dryness and irritation of the eyes, with possible development of Bitot spots (foamy conjunctival plaques).
- In severe cases, complaints of eye pain and vision loss due to corneal ulceration or keratomalacia.
Past Medical History
- History of malabsorption syndromes such as cystic fibrosis or celiac disease.
- Previous episodes of chronic diarrhea or gastrointestinal surgery.
- Chronic liver disease affecting vitamin A storage and metabolism.
Family History
- None typically relevant as vitamin A deficiency is not inherited.
Physical Exam Findings
- Presence of Bitot spots, which are foamy, triangular, gray-white patches on the conjunctiva.
- Dry, rough skin due to xerosis caused by impaired epithelial differentiation.
- Corneal keratomalacia, characterized by softening and ulceration of the cornea.
- Night blindness evidenced by delayed adaptation to darkness during eye examination.
Physical Exam Maneuvers
- Dark adaptation test to assess night blindness by measuring the time taken for eyes to adjust from bright to dim light.
- Slit-lamp examination to evaluate the presence of corneal xerosis and early keratomalacia.
- Visual acuity testing under low-light conditions to detect impaired rod photoreceptor function.
Common Comorbidities
- Malnutrition and protein-energy deficiency.
- Infectious diseases such as measles and diarrhea, which worsen vitamin A status.
- Chronic malabsorption syndromes like cystic fibrosis or celiac disease.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of vitamin A deficiency is based on clinical signs such as night blindness, xerophthalmia, and keratomalacia, combined with laboratory evidence of low serum retinol levels below 0.70 µmol/L. Additional findings may include follicular hyperkeratosis and increased susceptibility to infections. A thorough dietary history and assessment for malabsorption or liver disease are essential to identify underlying causes.
Lab & Imaging Findings
- Serum retinol levels decreased, confirming vitamin A deficiency.
- Reduced serum retinol-binding protein (RBP) levels indicating impaired vitamin A transport.
- No specific imaging findings; diagnosis is primarily clinical and laboratory-based.
Pathophysiology
Key Mechanisms
- Vitamin A deficiency impairs the production of rhodopsin, a pigment essential for low-light vision, leading to night blindness.
- Deficiency disrupts the maintenance of epithelial tissues, causing keratinization and dryness, particularly in the conjunctiva and cornea.
- Lack of vitamin A reduces the function of the immune system, increasing susceptibility to infections.
| Involvement | Details |
|---|---|
| Organs | Eye is the primary organ affected, with symptoms including xerophthalmia and night blindness. |
| Liver stores vitamin A and is involved in its metabolism and mobilization. | |
| Skin may show dryness and hyperkeratosis due to impaired epithelial maintenance. | |
| Tissues | Epithelial tissue integrity is compromised in vitamin A deficiency causing keratinization and dryness. |
| Retinal tissue is affected leading to impaired photoreceptor function and night blindness. | |
| Cells | Conjunctival epithelial cells are affected in vitamin A deficiency leading to xerosis and keratinization. |
| Rod photoreceptor cells in the retina require vitamin A derivatives for normal function and night vision. | |
| Goblet cells in the conjunctiva decrease in number causing reduced mucin production and dry eyes. | |
| Chemical Mediators | Retinoic acid acts as a signaling molecule regulating gene expression for epithelial cell differentiation. |
| 11-cis-retinal is the chromophore in rhodopsin essential for phototransduction in rod cells. |
Treatment
Pharmacological Treatments
Vitamin A supplementation
- Mechanism: Replenishes retinol stores to restore normal epithelial cell function and vision
- Side effects: headache, nausea, dizziness, increased intracranial pressure
Non-pharmacological Treatments
- Increase dietary intake of vitamin A-rich foods such as liver, dairy products, and orange or green leafy vegetables.
- Implement public health measures like food fortification and nutrition education to prevent deficiency.
- Ensure adequate breastfeeding in infants to provide natural vitamin A.
Pharmacological Contraindications
- Vitamin A supplementation is contraindicated in patients with hypervitaminosis A due to risk of toxicity.
- Use caution in patients with liver disease as vitamin A is hepatically metabolized.
Non-pharmacological Contraindications
- Dietary interventions may be inappropriate in patients with fat malabsorption syndromes where vitamin A absorption is impaired.
- Food fortification programs may be limited in regions with logistical or economic constraints.
Prevention
Pharmacological Prevention
- Oral vitamin A supplementation with high-dose retinyl palmitate or retinyl acetate.
- Periodic vitamin A dosing in high-risk populations to prevent deficiency.
Non-pharmacological Prevention
- Dietary diversification to include vitamin A-rich foods such as liver, dairy products, and orange/yellow vegetables.
- Breastfeeding promotion to provide infants with adequate vitamin A.
- Public health measures to reduce malnutrition and improve sanitation.
Outcome & Complications
Complications
- Corneal ulceration and keratomalacia leading to blindness.
- Increased risk of severe infections due to compromised mucosal barriers.
- Permanent visual impairment if untreated.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Vitamin A Deficiency versus Congenital Stationary Night Blindness
| Vitamin A Deficiency | Congenital Stationary Night Blindness |
|---|---|
| Night blindness develops later due to nutritional deficiency. | Night blindness is present from birth or early childhood without progression. |
| Bitot spots and conjunctival xerosis are present in vitamin A deficiency. | Normal conjunctiva without Bitot spots or xerosis. |
| ERG is typically normal in vitamin A deficiency. | Electroretinogram (ERG) shows characteristic abnormalities. |
Vitamin A Deficiency versus Keratoconjunctivitis Sicca (Dry Eye Syndrome)
| Vitamin A Deficiency | Keratoconjunctivitis Sicca (Dry Eye Syndrome) |
|---|---|
| Night blindness is a prominent symptom in vitamin A deficiency. | Dryness and irritation of the eyes without night blindness. |
| Bitot spots and corneal changes are specific to vitamin A deficiency. | Schirmer test shows decreased tear production. |
| Tear production is usually normal in vitamin A deficiency. | No Bitot spots or corneal ulceration related to vitamin deficiency. |
Vitamin A Deficiency versus Vitamin A Deficiency
| Vitamin A Deficiency | Vitamin A Deficiency |
|---|---|
| Night blindness is an early and characteristic symptom. | Night blindness is typically absent in early stages. |
| Bitot spots (foamy, white conjunctival plaques) are a hallmark sign. | Bitot spots on the conjunctiva are not present. |
| Xerophthalmia with corneal dryness and potential ulceration occurs in advanced deficiency. | Xerophthalmia and corneal ulceration are uncommon. |